TrialThe Lancet. Global health2023

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.

Xiaoqiu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.